Unicycive Therapeutics, Inc. (UNCY) Tops Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts UNCY Hot Sheet
Join SI Premium – FREE
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q3 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Circle board member resigns after nearly 13 years of service
- XORTX to voluntarily delist from TSX Venture Exchange
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
